Speed to market: Driving medtech growth with an outsourced commercial team

The current NHS environment demands fast, expert, and adaptable commercial strategies. Traditional recruitment models, characterised by long lead times, vacant territories, and high indirect costs, no longer offer the speed or agility required to capitalise on today's opportunities.

In this exclusive, 45-minute strategy session, you will receive direct insights from established industry leaders into a new commercial model. This model is specifically designed to navigate market uncertainties, establish immediate UK presence, and pilot new strategic initiatives while eliminating commercial risk.

Join CHASE CEO Graham Hawthorne and Commercial Consultant Tim Wheeldon to learn the expert strategy for capitalising on the NHS "Fit for the Future" 10-Year Plan and securing your path to sustainable growth.

This 45-minute session will cover expert strategy and critical insight, including:

• Leadership consensus: Insights from 50+ years of combined experience on the strategic path to accelerating time-to-market and minimising commercial risk in the UK.

• Capitalising on the NHS opportunity: Understand the strategic direction of the "Fit for the Future" 10-Year Plan and how to create a clear pathway for rapid medtech adoption.

• The flexible commercial model: Learn how an outsourced team provides a fast, expert, and adaptable alternative to traditional headcount, securing an immediate UK footprint.

Meet your speakers ‍

Graham Hawthorne, CEO, CHASE
‍As CEO of CHASE, Graham brings 30 years of leadership experience from roles within start-up, mid-sized, and multinational pharmaceutical service organisations. He has a strong track record in strategy, operations, and business development across the UK medtech and pharmaceutical sectors. Since joining CHASE in 2012, Graham has driven revenue growth across both outsourced and permanent recruitment divisions. His extensive network of senior industry contacts and focus on stakeholder management provide invaluable insight into creating effective commercial strategies for companies operating in the UK.

Tim Wheeldon, Consultant - Commercial Transformation 
Tim is a dynamic medtech leader with extensive experience driving commercial transformation at country and regional levels, managing budgets up to €1bn across 50+ countries. He possesses a strong track record in aligning strategy with financial goals and market impact, powered by a value-based approach to commercial excellence, segmentation, and execution. Tim's focus on innovation and talent development provides valuable perspective on building high-performing, adaptable commercial structures within the medtech sector.

(Host) Cat Metcalfe, Strategy & Insights Director, CHASE
‍Cat has 18 years of experience helping life sciences organisations understand and meet the needs of the NHS. Having worked extensively on patient-empowering programmes and medical education, Cat is passionate about finding collaborative, win-win solutions that benefit patients, the NHS, and its partners. She will host the discussion, ensuring it addresses the key strategic questions facing today's medtech leaders.